Hormonal health

Fibroid Medications: How the Newer Pills Work

Save

GnRH-antagonist pills relugolix and elagolix lower the hormone signals that fuel fibroid bleeding, and a small hormone add-back protects bone. In fibroid trials, most treated women had markedly lighter periods. The pills manage symptoms rather than cure fibroids, and their use is usually time-limited because of bone-density concerns.

Last updated: July 2026History

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What are relugolix and elagolix?

Relugolix and elagolix are oral gonadotropin-releasing hormone (GnRH) antagonists developed for the heavy bleeding that fibroids can cause. Fibroids are very common — most women develop at least one by age 50, according to the Office on Women's Health 1. Professional guidance now lists GnRH antagonists among the medical options for fibroid-related heavy periods 2.

The medicines block the pituitary signal that tells the ovaries to make estrogen and progesterone, and because fibroids grow in response to those hormones, lowering them reduces bleeding 3. To soften the low-estrogen effects of a full block, both come packaged with a small hormone add-back. Relugolix combination therapy pairs the antagonist with low-dose estradiol and a progestin in one daily pill 3.

How well do the newer fibroid pills work?

Clinical trials show the newer pills sharply cut menstrual blood loss. In the LIBERTY trials of relugolix combination therapy, about 73% of women reached a major reduction in bleeding, compared with fewer than 19% on placebo 3. Elagolix with hormone add-back gave a similar result in the Elaris fibroid studies, with roughly 68% to 77% of women improving across the two trials 4.

According to a comparative-effectiveness review, these medicines reliably lighten bleeding but do not make fibroids disappear, and bleeding often returns after they stop 5. Many women also notice less pelvic pressure. The pills are one option among several, alongside hormonal IUDs and tranexamic acid, for heavy menstrual bleeding 6.

What are the risks and limits?

Lowering estrogen carries trade-offs, and the most important one involves bone. Because sustained low estrogen thins bone, the hormone add-back is included to protect bone density, and use is generally kept time-limited; the pivotal trials followed treatment for up to about 24 months 3. Common side effects reported in studies include hot flashes, headache, and, less often, mood changes 34.

According to the practice guidance, GnRH antagonists are not used in pregnancy and are not a fertility treatment, because they suppress ovulation while taken 2. The pills treat symptoms rather than remove fibroids, so heavy bleeding usually returns within a few months of stopping 5. Cost and insurance coverage can be barriers, since these are brand-name products that often need prior authorization.

How do the pills compare with other options?

Medication is one branch of fibroid care, and the right branch depends on your goals and life stage. In the reproductive years, options such as a hormonal IUD or tranexamic acid can control bleeding, while GnRH-antagonist pills are useful when those fall short or before a planned procedure 56. During the perimenopausal transition, some women bridge with medication because fibroids often shrink after menopause when estrogen falls 1.

For fibroids distorting the uterine cavity or causing severe symptoms, procedures such as myomectomy or uterine artery embolization may be considered instead 5. Someone hoping to conceive soon is usually steered toward approaches that preserve fertility, since these pills prevent pregnancy while in use 2. Comparing uterine fibroid treatment options with a clinician helps match the plan to your priorities.

When to talk with a specialist

A gynecologist or a clinician with fibroid expertise can review your bleeding pattern, imaging, and pregnancy plans before recommending any medication. Bring a recent ultrasound and a symptom diary, since decisions hinge on fibroid size, number, and location 2. Useful questions cover how long the medication would be used, what the bone-health plan is, and what happens after stopping.

Understanding when heavy periods need a doctor matters, because bleeding that soaks through protection or brings on fatigue deserves a prompt visit and iron testing 1. Reviewing how to know if you have fibroids can help you frame questions about symptoms and next steps. Gale can help you prepare for that conversation.

Common questions

Mostly the latter. In trials the pills sharply reduced heavy bleeding and eased pressure, and some women saw modest shrinkage, but fibroids typically return toward their prior size and bleeding comes back within a few months of stopping. They manage symptoms rather than cure fibroids.

Their use is usually time-limited. Because the low-estrogen state they create can thin bone, the products include a hormone add-back and have generally been studied for use up to about 24 months. A clinician monitors bone health and revisits the plan periodically.

Generally no. GnRH-antagonist pills suppress ovulation and are not fertility treatments, so they are not used while trying to conceive or during pregnancy. Someone hoping to conceive is usually guided toward fertility-preserving options instead.

Older GnRH agonists, given by injection, first cause a temporary hormone surge and are usually limited to short courses before surgery. The newer oral antagonists work more quickly without that flare and are combined with add-back hormones, so they can be used longer with fewer menopausal side effects.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When fibroid bleeding needs prompt care

  • —Soaking through a pad or tampon every hour for several hours is heavy bleeding that is a reason to seek same-day clinician review.
  • —Dizziness, a racing heart, or shortness of breath with heavy periods can signal anemia and is a reason to seek prompt medical care.
  • —Sudden, severe pelvic pain with a known fibroid is a reason to contact your clinician or urgent care.
  • —New heavy bleeding after menopause is a reason to seek clinician evaluation, since it needs a separate workup.

This article is general health education, not medical advice. Whether a fibroid medication fits you depends on your bleeding pattern, imaging, and health history, and that decision belongs with a gynecologist or menopause-informed clinician.

Did this answer your question?

References

  1. 1.Office on Women's Health (U.S. HHS) (2025). Uterine fibroids. Office on Women's Health (womenshealth.gov), U.S. HHS. link ✓Establishes that uterine fibroids are common (most women develop at least one by age 50) and that fibroids are estrogen-responsive and often shrink after menopause.
  2. 2.American College of Obstetricians and Gynecologists (2021). Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000004401 ✓ACOG practice bulletin describing GnRH antagonists among medical management options for symptomatic fibroids, the rationale for time-limited use with add-back, and that these agents suppress ovulation and are not used in pregnancy.
  3. 3.Al-Hendy A, Lukes AS, Poindexter AN, et al. (2021). Treatment of uterine fibroid symptoms with relugolix combination therapy. New England Journal of Medicine. doi:10.1056/NEJMoa2008283 ✓LIBERTY 1 and 2 randomized trials showing relugolix combination therapy achieved a large reduction in menstrual blood loss in about 73% of treated women versus fewer than 19% on placebo, with follow-up out to roughly two years and add-back to protect bone.
  4. 4.Schlaff WD, Ackerman RT, Al-Hendy A, et al. (2020). Elagolix for heavy menstrual bleeding in women with uterine fibroids. New England Journal of Medicine. doi:10.1056/NEJMoa1904351 ✓Elaris UF randomized trials showing elagolix with hormone add-back reduced fibroid-related heavy menstrual bleeding in roughly 68% to 77% of treated women, with side effects including hot flashes and headache.
  5. 5.Hartmann KE, Fonnesbeck C, Surawicz T, Krishnaswami S, Andrews JC, Wilson JE, Velez-Edwards D, Kugley S, Sathe NA (2017). Management of Uterine Fibroids (Comparative Effectiveness Review No. 195). Agency for Healthcare Research and Quality (AHRQ). PMID 30789683 ✓AHRQ comparative-effectiveness review of fibroid treatments, supporting that medical therapy lightens bleeding but does not remove fibroids and that bleeding commonly returns after stopping, and framing procedural alternatives.
  6. 6.Bryant-Smith AC, Lethaby A, Farquhar C, Hickey M (2018). Antifibrinolytics for heavy menstrual bleeding. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD000249.pub2 ✓Cochrane review showing antifibrinolytic therapy (tranexamic acid) reduces heavy menstrual bleeding, supporting it as a non-hormonal comparator option.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library